Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)

NCT04764227 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04764227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04764227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 30, 2020
Completion date
March 30, 2027
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiotherapy, esophageal squamous cell carcinoma, esophagus cancer, postoperative, radiation therapy